Patent Assignment
Reel/Frame 061848/0323
Security Interest
Recorded: 2022-11-22
Pages: 9
Assignors
BAUSCH HEALTH IRELAND LIMITED
Executed: 2022-11-21
SALIX PHARMACEUTICALS, INC.
Executed: 2022-11-21
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(2)
Methods for Treating Irritable Bowel Syndrome (Ibs)
Use of Methylnaltrexone to Attenuate Tumor Progression
Application:
17/947,715 →
Publication:
US 2023/0181571
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 23, 2022
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 060869/0160 →
Assignment of Assignor's Interest
Aug 23, 2022
From: FORBES, WILLIAM; BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 060869/0091 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Interest
Nov 22, 2022
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 061848/0311 →
Security Interest
Nov 22, 2022
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 061848/0284 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →